Integrated pharmacological and Omega-3 therapy modulates immunometabolic pathways and neuro-ophthalmological outcomes in relapsing-remitting multiple sclerosis.
Ahmed Merza Mohammed T, Nouri Shawis T, Ahmad Merza Mohammad T, Al-Haideri M
Immunotherapy. 2026 May 27:1-11. PMID: 42200313.Abstract